2025
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
Walker J, Akiyama M, Artenie A, Cleland C, Lizcano J, Musyoki H, Nyakowa M, Cherutich P, Kurth A, Vickerman P. Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya. International Journal Of Drug Policy 2025, 140: 104824. PMID: 40328143, DOI: 10.1016/j.drugpo.2025.104824.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyHIV incidenceAssociated with lower HIV incidenceEffectiveness of HIV prevention interventionsViral suppressionRisk behaviorsReduced risk of HIV acquisitionIncrease ART uptakeHIV prevention interventionsRisk of HIV acquisitionLower HIV incidenceBio-behavioural surveyHIV viral loadProportion of peopleRespondent-driven samplingART uptakeDried blood spot samplesHIV outcomesReduction interventionsPreventive interventionsART coverageBlood spot samplesInjection risk behaviorsEvidence gapsHIV acquisition
2021
Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis
Ward Z, Stone J, Bishop C, Ivakin V, Eritsyan K, Deryabina A, Low A, Cepeda J, Kelly SL, Heimer R, Cook R, Altice FL, Litz T, Terlikbayeva A, El-Bassel N, Havarkov D, Fisenka A, Boshnakova A, Klepikov A, Saliuk T, Deshko T, Vickerman P. Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis. The Lancet HIV 2021, 9: e42-e53. PMID: 34895484, PMCID: PMC8762142, DOI: 10.1016/s2352-3018(21)00274-5.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyAgonist therapyAntiretroviral therapyPublic health approachHIV transmissionDrug useDynamic HIV transmission modelHealth approachIncremental cost-effectiveness ratioHIV transmission modelNational InstituteCost-effectiveness ratioCountry-specific costsHIV incidenceUNAIDS 90US National InstitutesART coverageWHO targetPWIDTherapyPay thresholdsInfectious diseasesCost savingsDrug abuseIncremental cost
2020
Do state insurance mandates alter ICSI utilization?
Zagadailov P, Seifer DB, Shan H, Zarek SM, Hsu AL. Do state insurance mandates alter ICSI utilization? Reproductive Biology And Endocrinology 2020, 18: 33. PMID: 32334609, PMCID: PMC7183130, DOI: 10.1186/s12958-020-00589-w.Peer-Reviewed Original ResearchConceptsIntracytoplasmic sperm injectionElective single embryo transferClinical pregnancyICSI usePreimplantation genetic testingESET rateState insurance mandatesTwin rateInsurance mandatesRetrospective cohort studyLive birth rateLower clinical pregnancyMale factor infertilitySingle embryo transferBirth rateTwin birth rateT-testICSI rateLower LBRStrength of associationCohort studyFactor infertilityART cyclesResultsFrom 2000ART coverage
2017
Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia
Ferro EG, Culbert GJ, Wickersham JA, Marcus R, Steffen AD, Pauls HA, Westergaard RP, Lee CK, Kamarulzaman A, Altice FL. Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia. Open Forum Infectious Diseases 2017, 4: ofw219. PMID: 28480230, PMCID: PMC5414088, DOI: 10.1093/ofid/ofw219.Peer-Reviewed Original ResearchHuman immunodeficiency virusT-cell countsAdvanced human immunodeficiency virusAntiretroviral therapyKey risk populationsKey populationsRisk populationsEvidence-based treatment guidelinesHuman immunodeficiency virus (HIV) incidenceClinician-level interventionsHypothetical clinical scenariosProportion of physiciansHigher CD4HIV patientsPhysician adherenceControl patientsTreatment guidelinesHIV incidenceImmunodeficiency virusART accessART coverageInternet-based surveyPhysicians' attitudesPrevention strategiesClinical scenarios
2015
Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model
Luo S, Han L, Lu H, Dou Z, Tao Q, Khoshnood K, Wu Z, Xu J. Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model. PLOS ONE 2015, 10: e0126893. PMID: 26039075, PMCID: PMC4454496, DOI: 10.1371/journal.pone.0126893.Peer-Reviewed Original ResearchBurden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan
Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, Dvoryak S, Rotberga S, Altice FL. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug And Alcohol Dependence 2015, 151: 68-75. PMID: 25861943, PMCID: PMC4447560, DOI: 10.1016/j.drugalcdep.2015.02.034.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyDrug injectionInfectious diseasesPrevalence of HCVSignificant independent correlatesLow HIV prevalenceHigh-endemic countriesHigh diagnostic rateEvidence-based addiction treatmentSubstance use disordersHealth assessment surveyHCV epidemicHepatitis BHCV diagnosisHIV statusHIV prevalenceART coverageHIV treatmentIndependent correlatesNew medicationsHIV epidemicHeterosexual riskHealth SurveyEndemic countriesHIV
2014
Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China
Lou J, Blevins M, Ruan Y, Vermund SH, Tang S, Webb GF, Shepherd BE, He X, Lu H, Shao Y, Qian HZ. Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China. PLOS ONE 2014, 9: e90985. PMID: 24626165, PMCID: PMC3953201, DOI: 10.1371/journal.pone.0090985.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyHIV epidemicCondom useHIV prevalenceART coverageCombination prevention strategiesHIV/AIDSHIV testingHIV incidenceCombination interventionsBeijing MSMPrevention strategiesPrevalence estimatesPrevalenceEpidemic expansionMenInterventionEpidemicIncidenceBasic reproduction numberPrevention scenariosCurrent coverageSexReproduction numberIntervention levelsThe potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa
Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG, Dodd PJ. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa. AIDS 2014, 28: s25-s34. PMID: 24468944, DOI: 10.1097/qad.0000000000000085.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyTB incidenceART expansionHIV treatment policyHIV-positive individualsART eligibility criteriaTuberculosis outcomesART eligibilitySurvival benefitTB burdenTB casesHIV transmissionART coverageHIV treatmentHIV epidemicMortality reductionPositive individualsEligibility criteriaTreatment policyART servicesTuberculosisIncidenceCurrent eligibilityIndependent mathematical modelsRecent findings
2012
Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates
Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertility And Sterility 2012, 99: 382-388.e7. PMID: 23102859, PMCID: PMC3561490, DOI: 10.1016/j.fertnstert.2012.09.026.Peer-Reviewed Original ResearchConceptsLive birth rateAge 40 yearsART cyclesART coverageElevated FSHOvarian reserveTreatment outcomesReproductive technology treatment outcomesSpecific infertility diagnosisState insurance coverageReproductive technology cyclesDiminished ovarian reserveProportion of cyclesCross-sectional studyBirth rateReporting System databaseInsurance mandatesMix of patientsProvider factorsInfertility diagnosisMAIN OUTCOMEFSHSignificant associationTreatment prognosisAdditional studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply